JBIO JBIO Change In Fair Value Of Convertible Notes Payable
Change In Fair Value Of Convertible Notes Payable at other companies
Other financials
Where this comes from
Reported directly by JBIO in its filing.
Tagged under the XBRL concept ck0001798749:ChangeInFairValueOfConvertibleNotesPayable.
The official record: JBIO’s 10-K, filed March 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about JBIO's change in fair value of convertible notes payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is JBIO's change in fair value of convertible notes payable?
- JBIO (JBIO) reported change in fair value of convertible notes payable of $0 in Q4 2025.
- How has JBIO's change in fair value of convertible notes payable changed year-over-year?
- JBIO's change in fair value of convertible notes payable decreased by 100.0% year-over-year, from $12.6M to $0.
- What does change in fair value of convertible notes payable mean?
- This metric represents the non-cash gain or loss resulting from the periodic revaluation of convertible debt instruments to their current fair market value. For biotechnology companies, this often reflects changes in the company's stock price and volatility, which impact the embedded conversion option. It is a non-operating item that can significantly impact net income without affecting cash flow.